InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Anderman Todd. Director active across 1 company, notably Ocular Therapeutix, INC. In total, 2 filings have been published. History available since 7 October 2024. The latest transaction was disclosed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations